|
N
|
259
|
32,204
| |
21
|
9708
| |
|
Age at diagnosis, median (IQR)
|
43 (34, 57)
|
34 (28, 43)
|
< 0.001
|
55 (42, 64)
|
33 (26, 42)
|
< 0.001
|
|
Diagnosis year
| | |
< 0.001
| | |
0.38
|
|
2004–2005
|
46 (18%)
|
6387 (20%)
| |
2 (10%)
|
1780 (18%)
| |
|
2006–2007
|
33 (13%)
|
6416 (20%)
| |
6 (29%)
|
1874 (19%)
| |
|
2008–2009
|
45 (17%)
|
6528 (20%)
| |
5 (24%)
|
1942 (20%)
| |
|
2010–2011
|
75 (29%)
|
6487 (20%)
| |
6 (29%)
|
1993 (21%)
| |
|
2012–2013
|
60 (23%)
|
6386 (20%)
| |
2 (10%)
|
2119 (22%)
| |
|
Race/ethnicity
| | |
< 0.001
| | |
0.62
|
|
Non-Hispanic White
|
157 (61%)
|
25,125 (78%)
| |
17 (81%)
|
7266 (75%)
| |
|
Non-Hispanic Black
|
47 (18%)
|
809 (3%)
| |
1 (5%)
|
311 (3%)
| |
|
Hispanic/Other
|
52 (20%)
|
5672 (18%)
| |
3 (14%)
|
2000 (21%)
| |
|
Unknown
|
3 (1%)
|
598 (2%)
| |
0 (0%)
|
131 (1%)
| |
|
Insurance
| | |
< 0.001
| | |
0.087
|
|
Uninsured
|
20 (8%)
|
3411 (11%)
| |
4 (19%)
|
1351 (14%)
| |
|
Private insurance
|
169 (65%)
|
24,575 (76%)
| |
9 (43%)
|
6339 (65%)
| |
|
Medicaid/Medicare/other government insurance
|
62 (24%)
|
3605 (11%)
| |
8 (38%)
|
1812 (19%)
| |
|
Unknown
|
8 (3%)
|
613 (2%)
| |
0 (0%)
|
206 (2%)
| |
|
Income (per year)
| | |
0.38
| | |
0.68
|
|
Less than $38 k
|
40 (15%)
|
3981 (12%)
| |
5 (24%)
|
1507 (16%)
| |
|
$38 k-62,999
|
115 (44%)
|
15,408 (48%)
| |
10 (48%)
|
4791 (49%)
| |
|
$63 k or greater
|
100 (39%)
|
12,407 (39%)
| |
6 (29%)
|
3256 (34%)
| |
|
Unknown
|
4 (2%)
|
408 (1%)
| |
0 (0%)
|
154 (2%)
| |
|
Percent in ZIP code without a high school degree
| | |
0.69
| | |
0.75
|
|
21% or greater
|
37 (14%)
|
4450 (14%)
| |
5 (24%)
|
1711 (18%)
| |
|
7–20.9%
|
147 (57%)
|
17,658 (55%)
| |
12 (57%)
|
5355 (55%)
| |
|
Less than 7%
|
71 (27%)
|
9716 (30%)
| |
4 (19%)
|
2496 (26%)
| |
|
Unknown
|
4 (2%)
|
380 (1%)
| |
0 (0%)
|
146 (2%)
| |
|
Residence
| | |
0.42
| | |
0.51
|
|
Metropolitan
|
221 (85%)
|
26,877 (84%)
| |
16 (76%)
|
7934 (82%)
| |
|
Urban/rural
|
38 (15%)
|
5327 (17%)
| |
5 (24%)
|
1774 (18%)
| |
|
Charlson-Deyo comorbidity score
| | |
0.016
| | |
< 0.001
|
|
0
|
237 (92%)
|
30,544 (95%)
| |
15 (71%)
|
9029 (93%)
| |
|
1 or more
|
22 (9%)
|
1660 (5%)
| |
6 (29%)
|
679 (7%)
| |
|
Stage
| | | | | |
0.21
|
|
Stage I
|
259 (100%)
|
32,204 (100%)
| |
–
|
–
| |
|
Stage II
|
–
|
–
| |
9 (43%)
|
5469 (56%)
| |
|
Stage III
|
–
|
–
| |
12 (57%)
|
4239 (44%)
| |
|
Treatment
| | |
< 0.001
| | |
< 0.001
|
|
No orchiectomy
|
0 (0%)
|
30 (0.1%)
| |
2 (10%)
|
634 (7%)
| |
|
Orchiectomy alone
|
250 (97%)
|
16,519 (51%)
| |
10 (48%)
|
1106 (11%)
| |
|
Orchiectomy + adjuvant therapy
|
9 (4%)
|
15,626 (49%)
| |
9 (43%)
|
7941 (82%)
| |
|
Other/unknown
|
0 (0%)
|
29 (0.1%)
| |
0 (0%)
|
27 (0.3%)
| |
|
Last contact or death, months from diagnosis, median (IQR)
|
N = 229
|
N = 28,855
|
< 0.001
|
N = 20
|
N = 8612
|
0.002
|
| |
41 (22, 62)
|
53 (29, 80)
| |
19 (8, 55)
|
47 (24, 75)
| |
|
Time from diagnosis to death, median (IQR)
|
N = 13
|
N = 747
| |
N = 14
|
N = 866
| |
| |
23 (18, 43)
|
31 (14, 58)
|
0.78
|
11 (7, 21)
|
13 (4, 28)
|
0.96
|
